Table 3.
Multivariate regression analysis for the association of TMAO with demographic characteristics between CHD or CHD-T2DM patients and control participants.
| Characteristic | CHD | CHD-T2DM | ||
|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | |
| HDL | 1.392 (0.218–8.868) | 0.726 | 0.275 (0.011–6.876) | 0.432 |
| Triglyceride | 1.144 (0.812–1.612) | 0.434 | 1.196 (0.765–1.870) | 0.434 |
| Lipoprotein (a) | 0.586 (0.045–7.657) | 0.682 | 1.357 (1.001–2.134) | 0.558 |
| hs-TnI | 2.599 (0.183–3.696) | 0.481 | 1.290 (1.001–1.831) | 0.285 |
| CKMB | 1.427 (0.994–2.048) | 0.054 | 1.250 (0.742–2.106) | 0.403 |
| TMAO | 3.469 (2.294–5.245) | 0.001 | 9.110 (4.427–18.750) | 0.001 |